Ascension Health Ventures (AHV) announced the final closing of its third venture capital fund, CHV III, L.P. The $225 million fund will invest in early- to later-stage healthcare companies that have the potential to deliver financial returns as well as support the strategic initiatives of the fund’s health system limited partners.
McKesson and MedVentive Performance Management and Care Coordination Expertise Support Better Health 2020 Strategy
CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft.
PathoGenetiX Inc., today announced that the Company received $7.5 million in the second closing of its Series B financing to support the development and commercialization of its Genome Sequence Scanning technology for bacterial strain identification.